Raji, Kamalraj and Aanandhi, Vijey M (2017) Regulatory Filing In Us and Eu: A Comparative View. Research Journal of Pharmacy and Technology, 10 (1). p. 286. ISSN 0974-3618
![[thumbnail of ShowPDF_Paper (3).aspx]](https://ir.vistas.ac.in/style/images/fileicons/archive.png)
ShowPDF_Paper (3).aspx
Download (261kB)
Abstract
Regulatory Affairs in pharmaceutical industry is dealing with all aspects of government affairs and to fulfill the
requirements of Pharma regulatory agency of the concerned nations and deals with obtaining the approval from
license, development of a pharmaceutical product to manufacturing,drug approval process and registration of
pharmaceutical products for sale and distribution in different regulated markets and for post marketing studies.
The pharmaceutical companies must adhere to the legislations that require drugs to be developed, tested, trialed,
and manufactured in accordance to the guidelines so that they are safe and patient’s well - being is protected.
This topic aims at reviewing about the basics of drug regulatory filing in pharmaceutical industry and to gain
knowledge about the different aspects of introducing drug product(s) into USFDA/Europe regulated market
Item Type: | Article |
---|---|
Subjects: | Pharmaceutical Chemistry and Analysis > Pharmaceutical Chemistry |
Divisions: | Pharmaceutical Chemistry and Analysis |
Depositing User: | Mr IR Admin |
Date Deposited: | 07 Oct 2024 05:45 |
Last Modified: | 07 Oct 2024 05:45 |
URI: | https://ir.vistas.ac.in/id/eprint/9250 |